A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study
Maritta Sauer,1 Carole Abbotts2 1Global Strategic Insights, Merck KGaA, Darmstadt, Germany; 2Pharmaceutical Market Research Consultant, London, UK Purpose: Adherence to recombinant human growth hormone (r-hGH) is critical to growth and other outcomes in patients with growth dis...
Main Authors: | Sauer M, Abbotts C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/a-new-pen-device-for-injection-of-recombinant-human-growth-hormone-a-c-peer-reviewed-article-PPA |
Similar Items
-
Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study
by: María Dolores Rodríguez Arnao, et al.
Published: (2019-09-01) -
Expression of Growth Hormone Receptors by Lymphocyte subpopulations in the Human tonsil
by: Olivier Thellin, et al.
Published: (1998-01-01) -
Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre
by: Maria Cristina Maggio, et al.
Published: (2018-09-01) -
Long-Lasting Growth Hormone Regulated by the Ubiquitin-Proteasome System
by: Myung-Sun Kim, et al.
Published: (2021-06-01) -
Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
by: Pleil Andreas M, et al.
Published: (2012-10-01)